Bing V. Li

489 total citations
16 papers, 328 citations indexed

About

Bing V. Li is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Bing V. Li has authored 16 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Pharmaceutical Science and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Bing V. Li's work include Inhalation and Respiratory Drug Delivery (9 papers), Drug Solubulity and Delivery Systems (5 papers) and Pharmaceutical studies and practices (5 papers). Bing V. Li is often cited by papers focused on Inhalation and Respiratory Drug Delivery (9 papers), Drug Solubulity and Delivery Systems (5 papers) and Pharmaceutical studies and practices (5 papers). Bing V. Li collaborates with scholars based in United States, Sweden and Thailand. Bing V. Li's co-authors include Lawrence X. Yu, Dale P. Conner, Badrul A. Chowdhury, Wallace P. Adams, Sau L. Lee, Sau Lawrence Lee, Robert Lionberger, Ben Forbes, David Christopher and Per Bäckman and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Pharmaceutical Sciences and The AAPS Journal.

In The Last Decade

Bing V. Li

16 papers receiving 316 citations

Peers

Countries citing papers authored by Bing V. Li

Since Specialization

Citations

This map shows the geographic impact of Bing V. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing V. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing V. Li more than expected).

Fields of papers citing papers by Bing V. Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing V. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing V. Li. The network helps show where Bing V. Li may publish in the future.

Co-authorship network of co-authors of Bing V. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Bing V. Li. A scholar is included among the top collaborators of Bing V. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing V. Li. Bing V. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug Substances 2024 ·Journal of Pharmaceutical Sciences ·(unknown), Bhagwant Rege, Andre Raw, Jingyue Yang, Khondoker Alam, (unknown), Liang Zhao, Patrick J. Faustino, Fang Wu, Diaá M. Shakleya, (unknown), Bing V. Li, (unknown), (unknown), (unknown), (unknown), Ashley B. Boam, Robert Lionberger, David A. Keire, Lawrence X. Yu	2
2	Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: Summary of workshop 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Yuqing Gong, (unknown), Miyoung Yoon, Hao Zhu, (unknown), Andrew C. Hooker, Murray P. Ducharme, Jogarao Gobburu, (unknown), Parmesh Gajjar, Bing V. Li, Raja Velagapudi, (unknown), Anna Schwendeman, James E. Polli, Lanyan Fang, Robert Lionberger, Liang Zhao	7
3	Scientific and regulatory activities initiated by the U.S. Food and drug administration to foster approvals of generic dry powder inhalers: Bioequivalence perspective 2022 ·Advanced Drug Delivery Reviews ·Bryan Newman, Andrew Babiskin, Elizabeth Bielski, (unknown), (unknown), Lanyan Fang, (unknown), (unknown), Bing V. Li, Markham C. Luke, (unknown), (unknown), Ross Walenga, Zhong Wang, Liang Zhao, Nashwa El‐Gendy, Craig M. Bertha, (unknown), (unknown)	12
4	Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective 2022 ·Advanced Drug Delivery Reviews ·Nashwa El‐Gendy, Craig M. Bertha, (unknown), (unknown), Andrew Babiskin, Elizabeth Bielski, (unknown), (unknown), Lanyan Fang, (unknown), (unknown), Bing V. Li, Markham C. Luke, (unknown), Bryan Newman, (unknown), Ross Walenga, Liang Zhao	11
5	Mechanistic modeling of generic orally inhaled drug products: A workshop summary report 2022 ·CPT Pharmacometrics & Systems Pharmacology ·Ross Walenga, (unknown), Brent A. Craven, P. Worth Longest, (unknown), Bryan Newman, Bo Olsson, Günther Hochhaus, Bing V. Li, Markham C. Luke, Liang Zhao, Andrzej Przekwas, Robert Lionberger	11
6	Scientific Considerations for the Review and Approval of First Generic Mometasone Furoate Nasal Suspension Spray in the United States from the Bioequivalence Perspective 2019 ·The AAPS Journal ·Qing Liu, (unknown), Bhawana Saluja, Changning Guo, Badrul A. Chowdhury, Robert Lionberger, Dale P. Conner, Bing V. Li	17
7	Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products 2016 ·The AAPS Journal ·Rong Wang, Dale P. Conner, Bing V. Li	9
8	In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches 2015 ·The AAPS Journal ·Ben Forbes, Per Bäckman, David Christopher, Myrna Dolovich, Bing V. Li, (unknown)	43
9	International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences 2015 ·The AAPS Journal ·(unknown), Sau L. Lee, Robert Lionberger, Stephanie Choi, Wallace P. Adams, (unknown), Badrul A. Chowdhury, Dale P. Conner, Rohit Katial, Susan L. Limb, John R. Peters, Lawrence X. Yu, Samantha Seymour, Bing V. Li	46
10	Application of the Modified Chi-Square Ratio Statistic in a Stepwise Procedure for Cascade Impactor Equivalence Testing 2014 ·The AAPS Journal ·Benjamin Weber, Sau L. Lee, Renishkumar Delvadia, Robert Lionberger, Bing V. Li, Yi Tsong, Günther Hochhaus	8
11	Biopharmaceutics Classification System-Based Biowaivers for Generic Oncology Drug Products: Case Studies 2014 ·AAPS PharmSciTech ·Nilufer Tampal, Haritha Mandula, Hongling Zhang, Bing V. Li, (unknown), Dale P. Conner	10
12	FDA Bioequivalence Standards 2014 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·Lawrence X. Yu, Bing V. Li	43
13	Bioequivalence for Locally Acting Nasal Spray and Nasal Aerosol Products: Standard Development and Generic Approval 2013 ·The AAPS Journal ·Bing V. Li, (unknown), Sau L. Lee, (unknown), Badrul A. Chowdhury, (unknown), Dale P. Conner	32
14	A Sensitivity Analysis of the Modified Chi-square Ratio Statistic for Equivalence Testing of Aerodynamic Particle Size Distribution 2013 ·The AAPS Journal ·Benjamin Weber, Sau L. Lee, Robert Lionberger, Bing V. Li, Yi Tsong, Günther Hochhaus	11
15	Common Reasons for “For-Cause” Inspections in Bioequivalence Studies Submitted to the Food and Drug Administration 2012 ·The AAPS Journal ·Bing V. Li, Barbara M. Davit, (unknown), (unknown), (unknown), (unknown), Sam Haidar, (unknown), (unknown), (unknown), Dale P. Conner	1
16	In Vitro Considerations to Support Bioequivalence of Locally Acting Drugs in Dry Powder Inhalers for Lung Diseases 2009 ·The AAPS Journal ·Sau Lawrence Lee, Wallace P. Adams, Bing V. Li, Dale P. Conner, Badrul A. Chowdhury, Lawrence X. Yu	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact